4.8 Article

Label-Free Luminescent Mesoporous Silica Nanoparticles for Imaging and Drug Delivery

期刊

THERANOSTICS
卷 3, 期 9, 页码 650-657

出版社

IVYSPRING INT PUBL
DOI: 10.7150/thno.6668

关键词

Silica nanoparticles; Drug delivery; Integrin alpha(v)beta(3); Bioimaging; Doxorubicin

资金

  1. NIH [5R00CA153772, RR005351/GM103390]
  2. Philbrook scholarship

向作者/读者索取更多资源

We report herein a straightforward and label-free approach to prepare luminescent mesoporous silica nanoparticles. We found that calcination at 400 degrees C can grant mesoporous organosilica nanoparticles with strong fluorescence of great photo-and chemical stability. The luminescence is found to originate from the carbon dots generated from the calcination, rather than the defects in the silica matrix as was believed previously. The calcination does not impact the particles' abilities to load drugs and conjugate to biomolecules. In a proof-of-concept study, we demonstrated that doxorubicin (Dox) can be efficiently encapsulated into these fluorescent mesoporous silica nanoparticles. After coupled to c(RGDyK), the nanoconjugates can efficiently home to tumors through interactions with integrin alpha(v)beta(3) overexpressed on the tumor vasculature. This calcination-induced luminescence is expected to find wide applications in silica-based drug delivery, nanoparticle coating, and immunofluorescence imaging.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据